Akari Therapeutics Stock Plan Amendment
Akari Therapeutics held a Special General Meeting where shareholders approved an amendment to the 2023 Equity Incentive Plan. The amendment increases the number of ordinary shares available for issuance by 144 billion shares, equivalent to 1.8 million American Depositary Shares (ADSs).